This inventor holds 2 USPTO granted patents. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1989-1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989-1991
Title: Mark E. Sobel: Innovating Cancer Diagnosis and Treatment
Introduction: Mark E. Sobel is a notable inventor based in Bethesda, MD, whose contributions in the field of cancer research have led to significant advancements in diagnostic tools and therapeutic strategies. With a total of two patents under his name, Sobel's work exemplifies the intersection of biotechnology and medicine.
Latest Patents: One of Sobel's latest patents is titled "Kit for Diagnosing Cancer Metastatic Potential," which describes a new NM23 gene and its relationship with the metastatic potential of tumor cells. This invention provides a critical approach for assessing cancer severity and guiding treatment options. Another significant patent is "Recombinant DNA Clone Encoding Laminin Receptor," which offers a recombinant cDNA clone encoding a cell surface receptor for laminin. This invention includes probes and methods that can diagnose the aggressiveness of carcinoma or evaluate the effectiveness of treatments for cancer cells.
Career Highlights: Mark E. Sobel works for the United States of America as represented by the Department of Health, contributing to vital research initiatives aimed at enhancing public health and advancing cancer therapies. His inventions are pivotal in enabling healthcare professionals to make more informed decisions regarding cancer treatment.
Collaborations: Throughout his career, Sobel has collaborated with prominent researchers in the field, including Lance A. Liotta and Patricia Schriver Steeg. These partnerships have fostered a collaborative environment that enhances innovation and drives forward the understanding of cancer biology.
Conclusion: Mark E. Sobel's contributions to cancer diagnostics and treatment illustrate his commitment to advancing healthcare through innovative inventions. His patents not only expand the scientific community's knowledge but also hold the potential to improve patient outcomes significantly. As research continues to evolve, Sobel’s work remains integral to the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile